ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 145 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $70,897 | -66.9% | 11,380 | -64.5% | 0.00% | -100.0% |
| Q3 2022 | $214,000 | +63.4% | 32,013 | +54.9% | 0.00% | 0.0% |
| Q2 2022 | $131,000 | +274.3% | 20,671 | +1199.2% | 0.00% | – |
| Q4 2015 | $35,000 | +169.2% | 1,591 | +195.2% | 0.00% | – |
| Q3 2015 | $13,000 | -86.7% | 539 | -55.2% | 0.00% | – |
| Q2 2015 | $98,000 | -60.6% | 1,202 | -55.2% | 0.00% | -100.0% |
| Q1 2015 | $249,000 | +215.2% | 2,686 | +38.0% | 0.00% | – |
| Q4 2014 | $79,000 | +68.1% | 1,946 | 0.0% | 0.00% | – |
| Q3 2014 | $47,000 | +6.8% | 1,946 | -30.5% | 0.00% | – |
| Q2 2014 | $44,000 | -25.4% | 2,800 | -28.8% | 0.00% | – |
| Q1 2014 | $59,000 | +268.8% | 3,935 | +246.7% | 0.00% | – |
| Q4 2013 | $16,000 | -94.2% | 1,135 | -92.3% | 0.00% | -100.0% |
| Q3 2013 | $278,000 | – | 14,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |